re: Ann: Presentation at BBY Life Sciences Co...
With few companies operating in the regenerative stem cell space that are listed on global markets, Proactive Investors expects investors will twig to the growth story that is Regeneus.
Given Regeneus’s impressive product pipeline, it is a matter of time.